🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy

RecruitingNAAges 40 Years - 80 YearsMaleUniversity Hospital Olomouc
NCT06981026 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: * Biopsy-confirmed localized prostate cancer (ICD code C.61). * Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND). * Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter. * No known urethral stricture or colostomy or chronic urinary catheterization. * No medical or current psychiatric disorders that precludes their participation in the study. * Status of the musculoskeletal system allowing physical exercise. * Urinary continent at baseline. * Has reliable internet and the skills/knowledge to use technologies use for the study. Exclusion criteria: * Other malignant tumors, except for benign skin carcinoma. * Active treatment for other oncological diagnoses. * Presence of preoperative urinary incontinence. * Diagnosed mental or cognitive disorders. * Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence. * Severe musculoskeletal disorders preventing active exercise * Inability to use required technologies
💊

What it tests

  • Telemedicine-based prehabilitation and postoperative rehabilitation protocol, including physical activity monitoring, respiratory and postural training, and guidance via telehealth tools.
📍

Where

1 site
Urology clinic, University hospital Olomouc
Olomouc, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy